It also arrests tumor cells in the G1 phase through the activation of p53 and pRB pathways, suppression of cyclinA1 and CtBP1, and upregulation of p21WAF1, p27KIP1, and CDK8 (Wei et al., 2019). The gene discussed is TP53; the disease is neoplasm.